Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Kerion mimicking an erosive pustular dermatosis of the scalp.

Magri F, Pranteda G, Federico A, Muscianese M, Pigliacelli F, D'arino A, Paolino G, Bottoni U, Pranteda G.

G Ital Dermatol Venereol. 2019 Feb;154(1):96-98. doi: 10.23736/S0392-0488.17.05673-5. No abstract available.

PMID:
30616337
2.

Sequential treatment of daylight photodynamic therapy and imiquimod 5% cream for the treatment of superficial basal cell carcinoma on sun exposed areas.

Paolino G, Didona D, Scarnò M, Tallarico M, Cantoresi F, Calvieri S, Mercuri SR, Piccolo D, Bottoni U, Kyriakou A, Cantisani C.

Dermatol Ther. 2019 Mar;32(2):e12788. doi: 10.1111/dth.12788. Epub 2018 Dec 21. No abstract available.

PMID:
30499211
3.

Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumour.

Malara N, Gentile F, Coppedè N, Coluccio ML, Candeloro P, Perozziello G, Ferrara L, Giannetto M, Careri M, Castellini A, Mignogna C, Presta I, Pirrone CK, Maisano D, Donato A, Donato G, Greco M, Scumaci D, Cuda G, Casale F, Ferraro E, Bonacci S, Trunzo V, Mollace V, Onesto V, Majewska R, Amato F, Renne M, Innaro N, Sena G, Sacco R, Givigliano F, Voci C, Volpentesta G, Guzzi G, Lavano A, Scali E, Bottoni U, Di Fabrizio E.

NPJ Precis Oncol. 2018 Nov 19;2:26. doi: 10.1038/s41698-018-0069-7. eCollection 2018.

4.

Prognostic correlation between vitamin D serological levels, Body Mass Index and clinical-pathological features in melanoma patients.

Moliterni E, Paolino G, Veronese N, Bottoni U, Corsetti P, Cardone M, Didona D, Lopez T, Calvieri S.

G Ital Dermatol Venereol. 2018 Oct;153(5):732-733. doi: 10.23736/S0392-0488.17.05652-8. No abstract available.

PMID:
30246955
5.

Neurodystrophic Hand Dermatitis: Sannino Barduagni Syndrome.

Bottoni U, Tamburrini S, Scali E, Dastoli S, Amoruso GF, Paolino G, Moliterni E, Grieco T, Pranteda G, Calvieri S.

Acta Dermatovenerol Croat. 2017 Dec;25(4):312-313.

PMID:
30064610
6.

Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy.

Neri L, Peris K, Longo C, Calvieri S, Frascione P, Parodi A, Eibenschuz L, Bottoni U, Pellacani G; Actinic Keratosis - TReatment Adherence INitiative (AK-TRAIN) study group.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):93-107. doi: 10.1111/jdv.15142. Epub 2018 Jul 8.

PMID:
29920789
7.

Melanoma in female patients: general features and focus on the impact of estro-progestinic pills in prognostic factors.

Paolino G, Moliterni E, Didona D, Corsetti P, Lopez T, Abbenante D, Calvieri S, Bottoni U.

G Ital Dermatol Venereol. 2018 Aug;153(4):582-585. doi: 10.23736/S0392-0488.17.05585-7. No abstract available.

PMID:
29767487
8.

Carbamazepine-induced necrotizing leukocytoclastic vasculitis with a 20-year latency.

Pranteda G, D 'arino A, Pigliacelli F, Pranteda G, Rampioni-Vinciguerra GL, Bottoni U.

G Ital Dermatol Venereol. 2018 Apr;153(2):285-286. doi: 10.23736/S0392-0488.16.05490-0. No abstract available.

PMID:
29564877
9.

Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis.

Nisticò S, Del Duca E, Torchia V, Gliozzi M, Bottoni U, Muscoli C.

Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418757925. doi: 10.1177/2058738418757925.

10.

Anticarcinogenic activities of sulforaphane are influenced by Nerve Growth Factor in human melanoma A375 cells.

Arcidiacono P, Stabile AM, Ragonese F, Pistilli A, Calvieri S, Bottoni U, Crisanti A, Spaccapelo R, Rende M.

Food Chem Toxicol. 2018 Mar;113:154-161. doi: 10.1016/j.fct.2018.01.051. Epub 2018 Jan 31.

PMID:
29407470
11.

Scleroderma with an update about clinico-pathological correlation.

Rongioletti F, Ferreli C, Atzori L, Bottoni U, Soda G.

G Ital Dermatol Venereol. 2018 Apr;153(2):208-215. doi: 10.23736/S0392-0488.18.05922-9. Epub 2018 Jan 24. Review.

12.

Non Melanoma Skin Cancer Pathogenesis Overview.

Didona D, Paolino G, Bottoni U, Cantisani C.

Biomedicines. 2018 Jan 2;6(1). pii: E6. doi: 10.3390/biomedicines6010006. Review.

13.

Vitamin D and melanoma: state of the art and possible therapeutic uses.

Paolino G, Moliterni E, Corsetti P, Didona D, Bottoni U, Calvieri S, Mattozzi C.

G Ital Dermatol Venereol. 2019 Feb;154(1):64-71. doi: 10.23736/S0392-0488.17.05801-1. Epub 2017 Dec 15. Review.

14.

Severe adverse drug reaction due to cypress sublingual immunotherapy.

Grieco T, Paolino G, Faina V, Moliterni E, Carnicelli G, Bottoni U, Calvieri S.

G Ital Dermatol Venereol. 2019 Jun;154(3):367-368. doi: 10.23736/S0392-0488.17.05782-0. Epub 2017 Nov 30. No abstract available.

PMID:
29192473
15.

Superiority of a vitamin B12-containing emollient compared to a standard emollient in the maintenance treatment of mild-to-moderate plaque psoriasis.

Del Duca E, Farnetani F, De Carvalho N, Bottoni U, Pellacani G, Nisticò SP.

Int J Immunopathol Pharmacol. 2017 Dec;30(4):439-444. doi: 10.1177/0394632017736674. Epub 2017 Oct 19.

16.

Antitumor activity and expression profiles of genes induced by sulforaphane in human melanoma cells.

Arcidiacono P, Ragonese F, Stabile A, Pistilli A, Kuligina E, Rende M, Bottoni U, Calvieri S, Crisanti A, Spaccapelo R.

Eur J Nutr. 2018 Oct;57(7):2547-2569. doi: 10.1007/s00394-017-1527-7. Epub 2017 Sep 1.

17.

Prognostic factors in head and neck melanoma according to facial aesthetic units.

Paolino G, Cardone M, Didona D, Moliterni E, Losco L, Corsetti P, Schipani G, Lopez T, Calvieri S, Bottoni U.

G Ital Dermatol Venereol. 2017 Jul 26. doi: 10.23736/S0392-0488.17.05685-1. [Epub ahead of print]

PMID:
28748684
18.

Dermatofibrosarcoma protuberans: when the age makes the difference.

Paolino G, Didona D, Bottoni U, Romaniello F, Corsetti P, Richetta AG, Calvieri S.

G Ital Dermatol Venereol. 2018 Jun;153(3):344-348. doi: 10.23736/S0392-0488.17.05435-9. Epub 2017 May 16.

PMID:
28509521
19.

Atopic dermatitis IL17A- and IFN-γ-producing lymphocytes: investigation in blood, chronic lesions and APT.

Grieco T, Faina V, Porzia A, Paolino G, Morrone S, Bottoni U, Calvieri S, Mainiero F.

J Eur Acad Dermatol Venereol. 2017 Oct;31(10):e438-e439. doi: 10.1111/jdv.14258. Epub 2017 May 2. No abstract available.

PMID:
28380262
20.

Serum tryptase levels in melanoma patients: case-control study and review of the literature.

Paolino G, Moliterni E, Didona D, Cardone M, Lopez T, Garelli V, Richetta AG, Bottoni U, Cantisani C, Rossi A, Calvieri S.

G Ital Dermatol Venereol. 2019 Feb;154(1):18-25. doi: 10.23736/S0392-0488.17.05524-9. Epub 2017 Jan 12. Review.

PMID:
28079340
21.

Innate immunity in cutaneous melanoma.

Mignogna C, Scali E, Camastra C, Presta I, Zeppa P, Barni T, Donato G, Bottoni U, Di Vito A.

Clin Exp Dermatol. 2017 Apr;42(3):243-250. doi: 10.1111/ced.13023. Epub 2017 Jan 4. Review.

PMID:
28052512
22.

Vitamin D receptor immunohistochemistry variability in sun-exposed and non-sun-exposed melanomas.

Paolino G, Panetta C, Cota C, Didona D, Moliterni E, Di Mattia C, De Vita G, Bottoni U, Donati P, Calvieri S.

Melanoma Res. 2017 Feb;27(1):17-23. doi: 10.1097/CMR.0000000000000311.

PMID:
27792059
23.

Skin lesions in patients treated with imatinib mesylate: a 5-year prospective study.

Paolino G, Didona D, Clerico R, Corsetti P, Ambrifi M, Bottoni U, Calvieri S.

Cutis. 2016 Jun;97(6):E12-6.

PMID:
27416091
24.

Inflammation and macrophage polarization in cutaneous melanoma: Histopathological and immunohistochemical study.

Scali E, Mignogna C, Di Vito A, Presta I, Camastra C, Donato G, Bottoni U.

Int J Immunopathol Pharmacol. 2016 Dec;29(4):715-719. Epub 2016 Jul 7.

25.

An unusual case of mammary Paget’s disease in a woman with psoriasis.

Alessio C, Scali E, Manti F, Amoruso GF, Marchese S, Riga B, Bottoni U, Tamburrini O.

J Biol Regul Homeost Agents. 2016 Apr-Jun;30(2):589-92.

PMID:
27358153
26.

Pharmacoeconomy of drugs used in the treatment of actinic keratoses.

Nisticò S, Torchia V, Gliozzi M, Bottoni U, Del Duca E, Muscoli C.

Int J Immunopathol Pharmacol. 2016 Dec;29(4):796-804. Epub 2016 May 11.

27.

Is the prognosis and course of acral melanoma related to site-specific clinicopathological features?

Paolino G, Bekkenk MW, Didona D, Eibenschutz L, Richetta AG, Cantisani C, Viti G, Carbone A, Buccini P, De Simone P, Ferrari A, Scali E, Calvieri S, Silipo V, Cigna E, Viti GP, Bottoni U.

Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):842-8.

28.

Serum tryptase levels in melanoma patients: first results of clinicopathological features.

Paolino G, Moliterni E, Lopez T, Cardone M, Macrì G, Garelli V, Richetta AG, Didona D, Bottoni U, Calvieri S.

Melanoma Res. 2016 Apr;26(2):207-8. doi: 10.1097/CMR.0000000000000231. No abstract available.

PMID:
26925985
29.

Cancer surveillance series: role of demographic aspects, altitude and latitude in the extracutaneous malignant melanoma in a residential study.

Paolino G, Didona D, Clerico R, DE Vita G, Corsetti P, Ambrifi M, Cantisani C, Bottoni U, Richetta AG, Lopez T, Calvieri S.

G Ital Dermatol Venereol. 2016 Apr;151(2):133-9. Epub 2016 Feb 18.

PMID:
26889723
30.

Daylight-Photodynamic Therapy for the Treatment of Actinic Keratosis in Different Seasons.

Cantisani C, Paolino G, Bottoni U, Calvieri S.

J Drugs Dermatol. 2015 Nov;14(11):1349-53.

PMID:
26580886
31.

Infrared Saliva Analysis of Psoriatic and Diabetic Patients: Similarities in Protein Components.

Bottoni U, Tiriolo R, Pullano SA, Dastoli S, Amoruso GF, Nisticò SP, Fiorillo AS.

IEEE Trans Biomed Eng. 2016 Feb;63(2):379-84. doi: 10.1109/TBME.2015.2458967. Epub 2015 Jul 21.

PMID:
26208262
32.

Improvement of survival in patients with melanoma and non-melanoma skin cancers compared to patients without double cutaneous malignancies.

Bottoni U, Paolino G, Didona D, Corsetti P, Clerico R, Cantisani C, Richetta AG, Arcidiacono V, Scali E, Pranteda G, Calvieri S.

Eur Rev Med Pharmacol Sci. 2015;19(9):1640-4.

33.

Dialysis-associated pseudoporphyria successfully treated with vitamin D. Report of two cases.

Pranteda G, Bottoni U, Tayefeh Jafari M, Pranteda G, De Micco S, Muscianese M, Menè P.

G Ital Dermatol Venereol. 2015 Jun;150(3):327-9.

PMID:
25946676
34.

Cutaneous manifestations in antiphospholipid syndrome.

Caporuscio S, Sorgi ML, Nisticò S, Pranteda G, Bottoni U, Carboni I, Del Duca E, Pranteda G.

Int J Immunopathol Pharmacol. 2015 Jun;28(2):270-3. doi: 10.1177/0394632015582344. Epub 2015 Apr 15.

PMID:
25875603
35.

Differences in clinicopathological features and distribution of risk factors in Italian melanoma patients.

Fava P, Astrua C, Chiarugi A, Crocetti E, Pimpinelli N, Fargnoli MC, Maurichi A, Rubegni P, Manganoni AM, Bottoni U, Catricalà C, Cavicchini S, Santinami M, Alaibac M, Annetta A, Borghi A, Calzavara Pinton P, Capizzi R, Clerico R, Colombo E, Corradin MT, De Simone P, Fantini F, Ferreli C, Filosa G, Girgenti V, Giulioni E, Guarneri C, Lamberti A, Lisi P, Nardini P, Papini M, Peris K, Pizzichetta MA, Salvini C, Savoia P, Strippoli D, Tolomio E, Tomassini MA, Vena GA, Zichichi L, Patrizi A, Argenziano G, Simonacci M, Quaglino P.

Dermatology. 2015;230(3):256-62. doi: 10.1159/000368775. Epub 2015 Jan 31.

36.

Evaluation of Ingenol mebutate efficacy for the treatment of actinic keratosis with Antera 3D camera.

Cantisani C, Paolino G, Corsetti P, Bottoni U, Didona D, Calvieri S.

Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):92-7.

37.

Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update.

Paolino G, Moliterni E, Didona D, Garelli V, Corsetti P, Lopez T, Richetta AG, Cantisani C, Bottoni U, Calvieri S.

Med Oncol. 2015 Jan;32(1):451. doi: 10.1007/s12032-014-0451-4. Epub 2014 Dec 17.

PMID:
25516505
38.

Association between autoimmune disease and cutaneous melanoma with regard to melanoma prognosis.

Bottoni U, Paolino G, Ambrifi M, Didona D, Albanesi M, Clerico R, Lido P, Brachini A, Corsetti P, Richetta AG, Cantisani C, Calvieri S.

Clin Exp Dermatol. 2015 Apr;40(3):254-9. doi: 10.1111/ced.12531. Epub 2014 Dec 5.

PMID:
25475359
39.

Basal cell carcinoma: differences according to anatomic location and clinical-pathological subtypes.

Pranteda G, Grimaldi M, Lombardi M, Pranteda G, Arcese A, Cortesi G, Muscianese M, Bottoni U.

G Ital Dermatol Venereol. 2014 Aug;149(4):423-6.

PMID:
25068230
40.

Granuloma annularis revealing Wegener's granulomatosis.

Del Porto F, Proietta M, Muscianese M, Tamburi F, Cifani N, Ferri L, Nisticò S, Bottoni U, Bruno G, Pranteda G.

Int J Immunopathol Pharmacol. 2014 Apr-Jun;27(2):273-8.

PMID:
25033485
41.

Melanoma and IFN alpha: potential adjuvant therapy.

Bottoni U, Clerico R, Paolino G, Corsetti P, Ambrifi M, Brachini A, Richetta A, Nisticò S, Pranteda G, Calvieri S.

J Biol Regul Homeost Agents. 2014 Apr-Jun;28(2):271-9.

PMID:
25001659
42.

Follow-up of cutaneous melanoma patients: a proposal for standardization.

Moscarella E, Ricci C, Borgognoni L, Bottoni U, Catricalà C, Dika E, Fanti PA, Landi C, Manganoni AM, Pellacani G, Peris K, Pimpinelli N, Quaglino P, Richetta A, Simonetti V, Stanganelli I, Testori A, Zalaudek I, Argenziano G.

G Ital Dermatol Venereol. 2014 Dec;149(6):633-8. Epub 2014 Jun 18. No abstract available.

PMID:
24938723
43.

Multiple skin ulcers due to Serratia marcescens in a immunocompetent patient.

Carlesimo M, Pennica A, Muscianese M, Bottoni U, Abruzzese C, Giubettini M, Pranteda G, Pranteda G.

G Ital Dermatol Venereol. 2014 Jun;149(3):367-70.

PMID:
24819766
44.

Pitted keratolysis, erythromycin, and hyperhidrosis.

Pranteda G, Carlesimo M, Pranteda G, Abruzzese C, Grimaldi M, De Micco S, Muscianese M, Bottoni U.

Dermatol Ther. 2014 Mar-Apr;27(2):101-4. doi: 10.1111/dth.12064. Epub 2013 May 24.

PMID:
24703267
45.

Thin melanoma and late recurrences: it is never too thin and never too late.

Richetta AG, Bottoni U, Paolino G, Clerico R, Cantisani C, Ambrifi M, Corsetti P, Calvieri S.

Med Oncol. 2014 Apr;31(4):909. doi: 10.1007/s12032-014-0909-4. Epub 2014 Mar 8.

PMID:
24610543
46.

Pemphigus vulgaris in a patient with arthritis and uveitis: successful treatment with immunosuppressive therapy and acyclovir.

Pranteda G, Carlesimo M, Bottoni U, Di Napoli A, Muscianese M, Pimpinelli F, Cordiali P, Laganà B, Pranteda G, Di Carlo A.

Dermatol Ther. 2014 Jul-Aug;27(4):215-8. doi: 10.1111/dth.12120. Epub 2014 Feb 18.

PMID:
24548566
47.

Role of steroid therapy in pseudoxanthoma elasticum-like papillary dermal elastolysis.

Pranteda G, Muscianese M, Marmo G, Fidanza L, Pranteda G, Tamburi F, Bottoni U, Nisticò S.

Int J Immunopathol Pharmacol. 2013 Oct-Dec;26(4):1013-8.

PMID:
24355240
48.

Pharmacological management of pediatric Kerion celsi.

Pranteda G, Muscianese M, Grimaldi M, Tuzi M, Pranteda G, Fidanza L, Tamburi F, Bottoni U, Nisticò S.

Int J Immunopathol Pharmacol. 2013 Oct-Dec;26(4):973-6.

PMID:
24355234
49.

Ink spot lentigo: singular clinical features in a case series of patients.

Bottoni U, Nisticò S, Amoruso GF, Schipani G, Arcidiacono V, Scali E, Tassone P, Greco M, Amorosi A.

Int J Immunopathol Pharmacol. 2013 Oct-Dec;26(4):953-5.

PMID:
24355230
50.

Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review.

Leporini C, Saullo F, Filippelli G, Sorrentino A, Lucia M, Perri G, Gattuta GL, Infusino S, Toscano R, Dima G, Olivito V, Paletta L, Bottoni U, De Sarro G.

J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S78-85. doi: 10.4103/0976-500X.120966.

Supplemental Content

Loading ...
Support Center